The immune system as drug target

Darren R. Flower

Research output: Contribution to journalArticle

Abstract

The immune system is perhaps the largest yet most diffuse and distributed somatic system in vertebrates. It plays vital roles in fighting infection and in the homeostatic control of chronic disease. As such, the immune system in both pathological and healthy states is a prime target for therapeutic interventions by drugs-both small-molecule and biologic. Comprising both the innate and adaptive immune systems, human immunity is awash with potential unexploited molecular targets. Key examples include the pattern recognition receptors of the innate immune system and the major histocompatibility complex of the adaptive immune system. Moreover, the immune system is also the source of many current and, hopefully, future drugs, of which the prime example is the monoclonal antibody, the most exciting and profitable type of present-day drug moiety. This brief review explores the identity and synergies of the hierarchy of drug targets represented by the human immune system, with particular emphasis on the emerging paradigm of systems pharmacology.

Original languageEnglish
Number of pages4
JournalImmunology and Immunogenetics Insights
Volume5
DOIs
Publication statusPublished - 9 Dec 2013

Fingerprint

Immune System
Pharmaceutical Preparations
Pattern Recognition Receptors
Computer Communication Networks
Major Histocompatibility Complex
Vertebrates
Immunity
Chronic Disease
Monoclonal Antibodies
Pharmacology
Infection

Bibliographical note

© the authors, publisher and licensee Libertas Academica Limited. This is an open-access article distributed under the terms of the Creative Commons
CC -BY-NC 3.0 License.

Keywords

  • adjuvants
  • antibody
  • biologic drug
  • drug design
  • immune system
  • major histocompatibility complex
  • natural products

Cite this

@article{40caad993e2d4e4b888075cfa7ba493b,
title = "The immune system as drug target",
abstract = "The immune system is perhaps the largest yet most diffuse and distributed somatic system in vertebrates. It plays vital roles in fighting infection and in the homeostatic control of chronic disease. As such, the immune system in both pathological and healthy states is a prime target for therapeutic interventions by drugs-both small-molecule and biologic. Comprising both the innate and adaptive immune systems, human immunity is awash with potential unexploited molecular targets. Key examples include the pattern recognition receptors of the innate immune system and the major histocompatibility complex of the adaptive immune system. Moreover, the immune system is also the source of many current and, hopefully, future drugs, of which the prime example is the monoclonal antibody, the most exciting and profitable type of present-day drug moiety. This brief review explores the identity and synergies of the hierarchy of drug targets represented by the human immune system, with particular emphasis on the emerging paradigm of systems pharmacology.",
keywords = "adjuvants, antibody, biologic drug, drug design, immune system, major histocompatibility complex, natural products",
author = "Flower, {Darren R.}",
note = "{\circledC} the authors, publisher and licensee Libertas Academica Limited. This is an open-access article distributed under the terms of the Creative Commons CC -BY-NC 3.0 License.",
year = "2013",
month = "12",
day = "9",
doi = "10.4137/III.S12145",
language = "English",
volume = "5",
journal = "Immunology and Immunogenetics Insights",
issn = "1178-6345",
publisher = "Libertas Academica Ltd.",

}

The immune system as drug target. / Flower, Darren R.

In: Immunology and Immunogenetics Insights, Vol. 5, 09.12.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The immune system as drug target

AU - Flower, Darren R.

N1 - © the authors, publisher and licensee Libertas Academica Limited. This is an open-access article distributed under the terms of the Creative Commons CC -BY-NC 3.0 License.

PY - 2013/12/9

Y1 - 2013/12/9

N2 - The immune system is perhaps the largest yet most diffuse and distributed somatic system in vertebrates. It plays vital roles in fighting infection and in the homeostatic control of chronic disease. As such, the immune system in both pathological and healthy states is a prime target for therapeutic interventions by drugs-both small-molecule and biologic. Comprising both the innate and adaptive immune systems, human immunity is awash with potential unexploited molecular targets. Key examples include the pattern recognition receptors of the innate immune system and the major histocompatibility complex of the adaptive immune system. Moreover, the immune system is also the source of many current and, hopefully, future drugs, of which the prime example is the monoclonal antibody, the most exciting and profitable type of present-day drug moiety. This brief review explores the identity and synergies of the hierarchy of drug targets represented by the human immune system, with particular emphasis on the emerging paradigm of systems pharmacology.

AB - The immune system is perhaps the largest yet most diffuse and distributed somatic system in vertebrates. It plays vital roles in fighting infection and in the homeostatic control of chronic disease. As such, the immune system in both pathological and healthy states is a prime target for therapeutic interventions by drugs-both small-molecule and biologic. Comprising both the innate and adaptive immune systems, human immunity is awash with potential unexploited molecular targets. Key examples include the pattern recognition receptors of the innate immune system and the major histocompatibility complex of the adaptive immune system. Moreover, the immune system is also the source of many current and, hopefully, future drugs, of which the prime example is the monoclonal antibody, the most exciting and profitable type of present-day drug moiety. This brief review explores the identity and synergies of the hierarchy of drug targets represented by the human immune system, with particular emphasis on the emerging paradigm of systems pharmacology.

KW - adjuvants

KW - antibody

KW - biologic drug

KW - drug design

KW - immune system

KW - major histocompatibility complex

KW - natural products

UR - http://www.scopus.com/inward/record.url?scp=84890280935&partnerID=8YFLogxK

U2 - 10.4137/III.S12145

DO - 10.4137/III.S12145

M3 - Article

AN - SCOPUS:84890280935

VL - 5

JO - Immunology and Immunogenetics Insights

JF - Immunology and Immunogenetics Insights

SN - 1178-6345

ER -